SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-030557
Filing Date
2021-06-02
Accepted
2021-06-02 16:37:52
Documents
1
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3573
  Complete submission text file 0001213900-21-030557.txt   5031
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Issuer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address
Shabahang Shahrokh (Reporting) CIK: 0001816754 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39336 | Film No.: 21989647